GOVX
GeoVax Labs, Inc.
There isn't enough reported data to score GOVX yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
GOVX Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
GOVX's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
GOVX PE Valuation
GOVX has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
GOVX Forward outlook
There aren't enough analyst estimates for GOVX to show an outlook.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
GOVX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$5,728.74 | +$1,741.26 |
| Q2 2024 | -$8,062.74 | -$1,942.74 |
| Q1 2024 | -$8,848.74 | -$3,088.74 |
| Q4 2023 | -$8,716.74 | -$1,246.74 |
| Q3 2023 | -$7,470.00 | +$18,810.00 |
| Q2 2023 | -$6,120.00 | +$21,420.00 |
| Q1 2023 | -$5,760.00 | +$22,050.00 |
| Q4 2022 | -$7,470.00 | +$19,890.00 |
LLY has the stronger earnings trend. Trailing diluted EPS is down 104% for GOVX versus LLY up 51%.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY's earnings per share have climbed steadily: $30.81 over the past year, up 51% from the year before, and higher year over year for 11 quarters in a row.
GOVX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $852.3K | +183% |
| Q1 2022 | $81.5K | -26% |
| Q4 2021 | $165K | -34% |
| Q3 2021 | $30.4K | -93% |
| Q2 2021 | $79.7K | -82% |
| Q1 2021 | $110.4K | -85% |
| Q4 2020 | $251.6K | -6.3% |
GOVX's revenue has slid since its 2024 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -636% | +1048 points |
| Q1 2025 | -330% | N/A |
| Q4 2024 | -965% | N/A |
| Q3 2024 | -210% | N/A |
| Q2 2024 | -1684% | N/A |
| Q1 2022 | -2978% | -1562 points |
| Q4 2021 | -8331% | -7800 points |
| Q3 2021 | -6416% | -6311 points |
GOVX's operating margin was −636% last quarter, up 1048 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over GOVX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
GOVX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.3M | +$1.9M |
| Q2 2026 | -$3.7M | +$687K |
| Q1 2026 | -$3.5M | +$2.4M |
| Q4 2025 | -$5M | +$2.8M |
| Q3 2025 | -$6.2M | +$3.1M |
| Q1 2025 | -$6M | -$298.8K |
| Q4 2024 | -$7.8M | +$2.5M |
| Q3 2024 | -$9.3M | -$4.2M |
GOVX has burned cash in almost every quarter: −$16M over the past year, against −$24M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over GOVX on cash generation, producing positive trailing cash flow while its opponent burns cash.
GOVX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +107% | +203K shares |
| 1 year | +1064% | +360K shares |
| 3 years | +13295% | +391K shares |
| 5 years | +452256% | +393K shares |
GOVX has 393,550 diluted shares, up 1064% from a year ago.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over GOVX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
GOVX Net Leverage
GOVX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
GOVX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.7 | Oversold |
| Stochastic | 1.4 | Oversold |
GOVX's weekly RSI is 29 (oversold) and its Stochastic is 1 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
GOVX PE vs Healthcare Sector
GOVX has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
GOVX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.42 | 62% below |
| 20 week MA | $12.9 | 84% below |
| 50 week MA | $43.4 | 95% below |
| 100 week MA | $349.0 | 99% below |
| 200 week MA | $1,907.6 | 100% below |
GOVX is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over GOVX on trend strength, trading above more of its moving averages.
GOVX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $143,928.0 | $29,520.0 | -79% |
| 2021 | $29,520.0 | $36,180.0 | +23% |
| 2022 | $36,180.0 | $5,106.5 | -86% |
| 2023 | $5,106.5 | $3,249.1 | -36% |
| 2024 | $3,249.1 | $1,476.0 | -55% |
| 2025 | $1,476.0 | $108.7 | -93% |
| 2026 YTD | $108.7 | $2.04 | -98% |
GOVX has finished four years in a row lower, and it's down 98% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over GOVX on returns for 2026, with the stronger performance.